Trial intelligence / Profile preview

Effect of imrecoxib on warfarin pharmacokinetics and pharmacodynamics in healthy subjects

ChiCTR-OPB-15005872Phase 4Completed

Sponsor
Union Hospital
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of imrecoxib and warfarin, sponsored by Union Hospital. Primary endpoints: Plasma R-warfarin concentration, Plasma S-warfarin concentration and 1 more. Started Nov 2014; status: completed.

02

Drugs

imrecoxibwarfarin

Beyond the preview

Go deeper on ChiCTR-OPB-15005872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPB-15005872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call